Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$20,000.00

Imaging tracers for cell tracking applications with magnetic resonance imaging (MRI) and positron emission tomography (PET)

EF 2012-13

Résumé
A growing number of emerging medical diagnostics and therapeutic procedures require the tracking of cells in vivo. In order to monitor and to quantify the fate of cells used in novel procedures for gene therapies, for Langerhans islet implantation (to cure diabetes), or for stem cell therapeutic approaches, it is necessary to use magnetic resonance imaging (MRI). MRI is now very well implanted in a majority of mid- and large-scale medical facilities. It is accessible and provides images of anatomical resolution without the use of ionising radiation. In order to visualise cells in vivo, the cells must be labelled with magnetic imaging probes made of the elements Fe, Gd, or Mn. These tracers either ""enhance"" or ""decrease"" the MRI signal to reveal the presence of labelled cells. In this research proposal, new Gd2O3 and MnO will be developed that will enable more quantitative, higher resolution cell tracking studies. Innovative nanoparticle surface treatments will be developed to prevent the degradation of particles submitted to harsh fluid environments. Then, to more precisely and more finely define the presence of small amounts of labelled cells, and to enhance the quantitative aspects of whole-body cell tracking, magnetic and radioactive nanoparticles will be developed. For this purpose, positron emitters (radioisotopes) will be used to ""dope"" or to ""label"" magnetic nanoparticles. Of all whole-body imaging modalities, positron emission tomography allows for the highest detection sensitivity. With the recent commercialization of dual PET/MRI scanners, which enable the coupling of high-resolution MRI with high-sensitivity PET, the new ""PET/MRI"" tracers developed in this research proposal will allow for more quantitative cell tracking studies. Finally, one aspect of the research program proposal addresses the development of a PET/MRI tracer synthesizer, a small equipment that may be advantageously installed directly in clinics and laboratories.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
355524-2012
Name nom
Fortin, MarcAndré
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
5
Application title
Imaging tracers for cell tracking applications with magnetic resonance imaging (MRI) and positron emission tomography (PET)
Keyword
NSERC
Application summary
A growing number of emerging medical diagnostics and therapeutic procedures require the tracking of cells in vivo. In order to monitor and to quantify the fate of cells used in novel procedures for gene therapies, for Langerhans islet implantation (to cure diabetes), or for stem cell therapeutic approaches, it is necessary to use magnetic resonance imaging (MRI). MRI is now very well implanted in a majority of mid- and large-scale medical facilities. It is accessible and provides images of anatomical resolution without the use of ionising radiation. In order to visualise cells in vivo, the cells must be labelled with magnetic imaging probes made of the elements Fe, Gd, or Mn. These tracers either ""enhance"" or ""decrease"" the MRI signal to reveal the presence of labelled cells. In this research proposal, new Gd2O3 and MnO will be developed that will enable more quantitative, higher resolution cell tracking studies. Innovative nanoparticle surface treatments will be developed to prevent the degradation of particles submitted to harsh fluid environments. Then, to more precisely and more finely define the presence of small amounts of labelled cells, and to enhance the quantitative aspects of whole-body cell tracking, magnetic and radioactive nanoparticles will be developed. For this purpose, positron emitters (radioisotopes) will be used to ""dope"" or to ""label"" magnetic nanoparticles. Of all whole-body imaging modalities, positron emission tomography allows for the highest detection sensitivity. With the recent commercialization of dual PET/MRI scanners, which enable the coupling of high-resolution MRI with high-sensitivity PET, the new ""PET/MRI"" tracers developed in this research proposal will allow for more quantitative cell tracking studies. Finally, one aspect of the research program proposal addresses the development of a PET/MRI tracer synthesizer, a small equipment that may be advantageously installed directly in clinics and laboratories.